Search research articles
Contact Us
Filters
Showing results (21-30 of 34) with videos related to
Page
of 4
Sort By:
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
August 10, 2020
Early identification of COVID-19 cytokine storm and treatment with anakinra or tocilizumab
Annette Langer-Gould, Jessica B Smith, Edlin G Gonzales, et al.
Neurology
|
April 9, 2026
Comparative Effectiveness of Rituximab Dosed Every 6 and 12 Months in Relapsing Multiple Sclerosis
Annette Langer-Gould, Bonnie H Li, Jessica B Smith, et al.
Applied Optics
|
June 10, 2024
Method for the production of a compact source of atomic line spectra in the vacuum ultraviolet
Jennifer S Hare, David M Wilmouth, Jessica B Smith, et al.
Neurology
|
December 22, 2025
Comparative Effectiveness of Rituximab Dosed Every 6 and 12 Months in Relapsing Multiple Sclerosis
Annette Langer-Gould, Bonnie H Li, Jessica B Smith, et al.
Science (New York, N.Y.)
|
May 11, 2013
Clarifying the dominant sources and mechanisms of cirrus cloud formation
Daniel J Cziczo, Karl D Froyd, Corinna Hoose, et al.
Nutrients
|
March 3, 2018
MS Sunshine Study: Sun Exposure But Not Vitamin D Is Associated with Multiple Sclerosis Risk in Blacks and Hispanics
Annette Langer-Gould, Robyn Lucas, Anny H Xiang, et al.
Nutrients
|
February 8, 2018
Vitamin D-Binding Protein Polymorphisms, 25-Hydroxyvitamin D, Sunshine and Multiple Sclerosis
Annette Langer-Gould, Robyn M Lucas, Anny H Xiang, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
October 16, 2020
Seafood, fatty acid biosynthesis genes, and multiple sclerosis susceptibility
Annette Langer-Gould, Lucinda J Black, Emmanuelle Waubant, et al.
Neurology
|
April 15, 2020
Pregnancy-related relapses and breastfeeding in a contemporary multiple sclerosis cohort
Annette Langer-Gould, Jessica B Smith, Kathleen B Albers, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
March 19, 2026
De-escalating low-dose rituximab up to every 24-month infusions and the risk of disease activity in people with relapsing multiple sclerosis who were stable the first year on therapy
Annette M Langer-Gould, Jessica B Smith, Allen Scott Nielsen, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 34) with videos related to
Sort By:
Page
of 4
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
August 10, 2020
Early identification of COVID-19 cytokine storm and treatment with anakinra or tocilizumab
Annette Langer-Gould, Jessica B Smith, Edlin G Gonzales, et al.
Neurology
|
April 9, 2026
Comparative Effectiveness of Rituximab Dosed Every 6 and 12 Months in Relapsing Multiple Sclerosis
Annette Langer-Gould, Bonnie H Li, Jessica B Smith, et al.
Applied Optics
|
June 10, 2024
Method for the production of a compact source of atomic line spectra in the vacuum ultraviolet
Jennifer S Hare, David M Wilmouth, Jessica B Smith, et al.
Neurology
|
December 22, 2025
Comparative Effectiveness of Rituximab Dosed Every 6 and 12 Months in Relapsing Multiple Sclerosis
Annette Langer-Gould, Bonnie H Li, Jessica B Smith, et al.
Science (New York, N.Y.)
|
May 11, 2013
Clarifying the dominant sources and mechanisms of cirrus cloud formation
Daniel J Cziczo, Karl D Froyd, Corinna Hoose, et al.
Nutrients
|
March 3, 2018
MS Sunshine Study: Sun Exposure But Not Vitamin D Is Associated with Multiple Sclerosis Risk in Blacks and Hispanics
Annette Langer-Gould, Robyn Lucas, Anny H Xiang, et al.
Nutrients
|
February 8, 2018
Vitamin D-Binding Protein Polymorphisms, 25-Hydroxyvitamin D, Sunshine and Multiple Sclerosis
Annette Langer-Gould, Robyn M Lucas, Anny H Xiang, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
October 16, 2020
Seafood, fatty acid biosynthesis genes, and multiple sclerosis susceptibility
Annette Langer-Gould, Lucinda J Black, Emmanuelle Waubant, et al.
Neurology
|
April 15, 2020
Pregnancy-related relapses and breastfeeding in a contemporary multiple sclerosis cohort
Annette Langer-Gould, Jessica B Smith, Kathleen B Albers, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
March 19, 2026
De-escalating low-dose rituximab up to every 24-month infusions and the risk of disease activity in people with relapsing multiple sclerosis who were stable the first year on therapy
Annette M Langer-Gould, Jessica B Smith, Allen Scott Nielsen, et al.
Page
of 4